$SNPS

Synopsys (SNPS) vs Cadence (CDNS): Which is a Better Stock to Buy?

Synopsys (SNPS) and Cadence (CDNS) are major suppliers of chip design software. SNPS reported $9.42B revenue, up 42.4% due to the Ansys acquisition, with operating margin at 14.52% and debt at $10.84B. CDNS had $5.84B revenue, up 24.2% organically, with a 28.58% margin and $2.65B debt. Both benefit from high customer switching costs.

Original reporting
Published Sep 30, 2026, 11:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 12:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys (SNPS) vs Cadence (CDNS): Which is a Better Stock to Buy? — source image
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

Provides analytical perspective but no new corporate event; serves mainly as informational content for investors evaluating the two stocks.

02

Market read

Useful for investors comparing the two firms, but lacks fresh news that would drive immediate trading decisions.

03

What to watch

Potential impact of AI‑driven design tools, macro‑chip demand trends, and upcoming regulatory scrutiny are not addressed.

Relevance 4/10Novelty 2/10Timing: none

Background

The piece is a side‑by‑side comparison of Synopsys and Cadence, focusing on revenue growth, margins, debt, and valuation multiples after Synopsys' Ansys acquisition.

Company-level read

Ticker impact

$SNPSNeutralMedium confidence
Context

The article compares Synopsys' recent acquisition of Ansys and its higher debt levels to Cadence, providing a fresh comparative analysis of the two companies.

Expected impact

uncertain, no clear catalyst for immediate price movement

Evidence & confidence

The article is an opinion/comparison piece lacking new earnings, deal or regulatory information; traders may weigh the analysis but no direct actionable trigger is present.

$CDNSNeutralMedium confidence
Context

The article contrasts Cadence's organic growth and lower debt with Synopsys, presenting a comparative view of the two chip‑design leaders.

Expected impact

uncertain, no clear catalyst for immediate price movement

Evidence & confidence

The article is an opinion/comparison piece lacking new earnings, deal or regulatory information; traders may weigh the analysis but no direct actionable trigger is present.

Market effects

Highlights the duopoly in chip‑design software, but offers no new sector‑wide catalyst.

U.S. semiconductor design sector; no immediate regional effect.

Limited to investors tracking Synopsys and Cadence.

Counterpoint

Without fresh data, the comparative advantage may be overstated; investors should wait for upcoming earnings or guidance releases.

Key entities

  • Synopsys, Inc.

    Chip‑design software provider that acquired Ansys.

  • Cadence Design Systems, Inc.

    Chip‑design software provider with organic growth.

Related articles

$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.

$SNPSMed

Morgan Stanley Raises Synopsys (SNPS) Price Target Amid AI Tailw

Morgan Stanley raised Synopsys' (SNPS) price target to $574 from $550, citing AI growth potential. SNPS shares dipped 0.8% premarket. GF Value™ estimates intrinsic value at $661.95, 32.8% above current price. SNPS has a GF Score™ of 93/100, reflecting strong growth and profitability. The stock's P/E ratio is 78.61x, below its 5-year median of 59.07x.